Category: Belgium

  • UCB’s FDA setback delays competition in U.S. with blockbuster J&J psoriasis drug

    The FDA cited manufacturing issues in turning down UCB’s application seeking approval for bimekizumab, an antibody drug developed to treat moderate-to-severe plaque psoriasis. Bimekizumab is already approved and available in other markets around world, but the FDA rejection delays UCB’s antibody drug from competing in the U.S. for now.

  • Belgium’s Precirix raises €80m to fund radiopharma aspirations

    Precirix has raised €80 million ($88 million) in a second-round financing that will be used to advance multiple radiopharmaceutical candidates for cancer through clinical development. The Belgian biotech, which was spun out from the Vrije Universiteit Brussel in 2014, is developing a pipeline of radio-labelled, single-chain antibodies led by CAM-H2, currently in a phase 1/2 […]

  • UCB is expanding its reach in epilepsy with $1.9B Zogenix acquisition

    Epilepsy is a small part of UCB’s neurology pipeline, but its proposed Zogenix acquisition would broaden the Belgium-based drugmaker’s ability to address that market. Zogenix’s Fintepla is approved in the U.S. and Europe for a rare type of epilepsy called Dravet syndrome, and is in development for other rare epilepsies.

  • GSK joins chase for hot cancer target, paying iTeos $625M in new alliance

    GlaxoSmithKline is paying iTeos Therapeutics $625 million up front to share in the development of an antibody that targets the TIGIT protein, a hot target in cancer immunotherapy R&D. The deal comes less than a month after rival Bristol Myers Squibb inked its own deal securing rights to a TIGIT-targeting Agenus drug.

  • Belgium halts dosing of J&J COVID vaccine in under 41s after death

    Belgium’s Ministry of Health has paused dosing of people under the age of 41 with Johnson & Johnson’s one-shot COVID-19 vaccine, following the death of a woman from what appeared to be a blood clot-related condition.  The unnamed woman – who was under the age of 40 – died on 21 May after being admitted […]

  • France and Germany threaten AstraZeneca over vaccine shortage

    Warning of ‘legal commitment’ and concern that doses might have been diverted from the EU to the UK Coronavirus – latest updates See all our coronavirus coverage France and Germany have threatened legal action against the Anglo-Swedish pharmaceutical company AstraZeneca in the row over a shortage of coronavirus vaccine in the EU. Talks between the […]

  • EU could block millions of Covid vaccine doses from entering UK

    European commission says new mechanism will give national regulators power to refuse exports Coronavirus – latest updates See all our coronavirus coverage Millions of doses of vaccines could be blocked from entering Britain from the EU within days, as part of Brussels’ response to a shortage of doses among its member states. The European commission […]

  • Belgian minister tweets EU’s Covid vaccine price list to anger of manufacturers

    Pharmaceutical companies complain of breach of confidentiality after amount EU has agreed to pay for leading vaccines goes public Coronavirus – latest updates See all our coronavirus coverage A Belgian minister has inadvertently blown the lid off a sensitive and commercial secret – the price that the EU has agreed to pay for the leading […]